SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-23-000542
Filing Date
2023-08-17
Accepted
2023-08-17 11:46:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2865
  Complete submission text file 0001971857-23-000542.txt   4216
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Subject) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40551 | Film No.: 231180627
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CARA THERAPEUTICS, INC. 1 PARROTT DRIVE SHELTON CT 06484
Business Address
Ives Jeffrey L. (Reporting) CIK: 0001614096 (see all company filings)

Type: 144